In fact, in our studies, we found that Dicer1e silencing could indeed enhance the chemosensitivity of cancer cells to cisplatin, thus, implying that targeting of Dicer1e could be an effective strategy to sensitizing oral cancer cells to chemotherapeutics. Here, DICER1 is linked to cancer.